210 related articles for article (PubMed ID: 14158826)
1. ENDOCRINE ABLATIVE PROCEDURES FOR RECURRENT AND INOPERABLE BREAST CARCINOMA.
HAIRSTON P; ALRICH EM
Va Med Mon (1918); 1964 Jun; 91():240-3. PubMed ID: 14158826
[No Abstract] [Full Text] [Related]
2. [ENDOCRINE TREATMENT OF ADVANCED MAMMARY CANCER].
JADRESIC A; PABST I; POBLETE M
Rev Med Chil; 1964 Feb; 92():132-9. PubMed ID: 14165297
[No Abstract] [Full Text] [Related]
3. URINARY GONADOTROPHINS IN POST-MENOPAUSAL WOMEN WITH BREAST CANCER.
MARTIN FI
Br Med J; 1964 Aug; 2(5405):351-3. PubMed ID: 14160226
[No Abstract] [Full Text] [Related]
4. FACT AND FALLACY IN THE HORMONAL CONTROL OF BREAST CANCER.
STOLL BA
Med J Aust; 1964 Jun; 1():980-2. PubMed ID: 14170462
[No Abstract] [Full Text] [Related]
5. [ENDOCRINE SURGERY IN METASTASIZING BREAST CANCER].
SJOEGREN B
Nord Med; 1963 Dec; 70():1357-62. PubMed ID: 14103688
[No Abstract] [Full Text] [Related]
6. SURVIVAL OF WOMEN WITH HORMONALLY TREATED BREAST CANCER.
GOLDENBERG IS; BAILAR JC; LOWRY R
Surg Gynecol Obstet; 1964 Oct; 119():785-9. PubMed ID: 14211212
[No Abstract] [Full Text] [Related]
7. PALLIATIVE MANAGEMENT OF METASTATIC CARCINOMA OF THE BREAST.
PALM ET
GP; 1964 Apr; 29():126-30. PubMed ID: 14137554
[No Abstract] [Full Text] [Related]
8. SEVEN-YEAR SURVIVAL AFTER BILATERAL ADRENALECTOMY AND OOPHORECTOMY FOR CARCINOMATOSIS.
TAYLOR H
Proc R Soc Med; 1964 Aug; 57(8):676-8. PubMed ID: 14195856
[No Abstract] [Full Text] [Related]
9. MEDICAL MANAGEMENT IN CARCINOMA OF THE BREAST.
TAYLOR SG
Radiology; 1964 Aug; 83():263-7. PubMed ID: 14207416
[No Abstract] [Full Text] [Related]
10. TREATMENT OF ADVANCED CARCINOMA OF THE BREAST. PROGRESS IN THERAPY DURING THE PAST DECADE.
GREEN RB; SETHI RS; LINDNER HH
Am J Surg; 1964 Jul; 108():107-21. PubMed ID: 14182428
[No Abstract] [Full Text] [Related]
11. [Ablative endocrine treatment of advanced or metastasizing breast cancer. Criteria of patient selection].
Bocci A; Campagnoli C
Minerva Chir; 1976 Nov; 31(22):1371-6. PubMed ID: 1012556
[No Abstract] [Full Text] [Related]
12. URINARY STEROID ESTIMATIONS IN THE PREDICTION OF RESPONSE TO ADRENALECTOMY OR HYPOPHYSECTOMY.
ATKINS H; BULBROOK RD; FALCONER MA; HAYWARD JL; MACLEAN KS; SCHURR PH
Lancet; 1964 Nov; 2(7370):1133-6. PubMed ID: 14213566
[No Abstract] [Full Text] [Related]
13. CARCINOMA OF THE BREAST, THERAPEUTIC DILEMMA THE GORDON RICHARDS MEMORIAL LECTURE--1964.
CARPENDER JW
J Can Assoc Radiol; 1964 Mar; 15():4-13. PubMed ID: 14135476
[No Abstract] [Full Text] [Related]
14. THE ENDOCRINE TREATMENT OF METASTATIC BREAST CANCER.
HORTLING H
Geriatrics; 1965 Jan; 20():51-60. PubMed ID: 14249988
[No Abstract] [Full Text] [Related]
15. TREATMENT OF RECURRENT AND METASTATIC CARCINOMA OF THE BREAST.
BOWMAN JT
Southwest Med; 1965 Feb; 46():45-51. PubMed ID: 14257922
[No Abstract] [Full Text] [Related]
16. ADJUNCTS TO THE TREATMENT OF BREAST CANCER.
HAYWARD JL
Natl Cancer Inst Monogr; 1964 Oct; 15():113-24. PubMed ID: 14248000
[No Abstract] [Full Text] [Related]
17. SELECTIVE CRITERIA FOR SURGICAL REMOVAL OF THE ENDOCRINE GLANDS IN ADVANCED BREAST CANCER.
FAIRGRIEVE J
Surg Gynecol Obstet; 1965 Feb; 120():371-85. PubMed ID: 14257953
[No Abstract] [Full Text] [Related]
18. [Endocrine therapy of the metastatic breast cancer. I. Ablative hormonal therapy (ovariectomy, adrenalectomy, hypophysectomy)].
Gacci G; Torre GC; Pedotti G; Gannizzo G
Acta Obstet Ginecol Hisp Lusit; 1977 Dec; 25(9):519-28. PubMed ID: 612117
[No Abstract] [Full Text] [Related]
19. THE MANAGEMENT OF DISSEMINATED CANCER OF THE BREAST.
THORLAKSON TK
Winnipeg Clin Q; 1964 Mar; 17():9-21. PubMed ID: 14133561
[No Abstract] [Full Text] [Related]
20. Endocrine ablative therapy of metastatic breast cancer.
Binder SC; Flynn WJ; Pass LM
CA Cancer J Clin; 1977; 27(6):354-9. PubMed ID: 73405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
